Follow Rediff on:

rediff.com
Rediffmail Money rediffGURUS BusinessEmail
March 03, 2026 IST 03:26:22

Rediff-TV 📺

This browser does not support the video element.

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
2 days ago

Duration: 0h 4m 51s

Abbott Bets On Semaglutide Boom

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Uploaded by: Rediff Video Desk on Sat, 28 Feb 2026 11:53:10 +0530

Views: 42

Tags: India, Novo Nordisk, Abbott, Ozempic, Emcure Pharma, Semaglutide Boom, Wegovy, Mounjaro, Extensior, Lilly

Watch More Videos

NEWS

Hezbollah intelligence head killed in Israel's Beirut attack

4 hours ago

See More >

MOVIES

Holi Songs You Haven't Heard

8 hours ago

See More >

BUSINESS

AI Summit: RIL, Adani, Tata, Google, Lightspeed pledged $240 bn investment

3 hours ago

See More >

GET AHEAD

8 Places Where Holi Is Celebrated Differently

8 hours ago

See More >

CRICKET

From 2007 Glory to 2022 Drama: Rohit Revisits India-Pak T20 WC Memories

3 hours ago

See More >

SPORTS

Four Teams Vie for Finals Berth in DP World PGTI's 72 The League

7 hours ago

See More >

hourly

1 am News Flash – March 3, 2026

2 hours ago

See More >
© 2026 Rediff.com - Feedback - About us - Grievances - Advertise with us